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Abstract.  Mechanisms of cell interaction with fibro- 
nectin have been studied with proteolytic fibronectin 
fragments that have well-defined ligand binding prop- 
erties.  Results of a previous study (Rogers, S.  L., J. B. 
McCarthy, S. L. Palm,  L. T. Furcht, and P. C. Le- 
tourneau,  1985, Jr. Neurosci.,  5:369-378) demonstrated 
that (a) central  (CNS) and peripheral  (PNS) nervous 
system neurons adhere to, and extend neurites on a 
33-kD carboxyl terminal  fibronectin fragment that also 
binds heparin,  and (b) neurons from the PNS, but not 
the CNS, have stable interactions with a 75-kD cell- 
binding fragment and with intact fibronectin.  In the 
present study domain-specific reagents were used in 
inhibition assays to further differentiate cell surface in- 
teractions with the two fibronectin domains,  and to 
define the significance of these domains to cell interac- 
tions with the intact fibronectin molecule.  These re- 
agents are (a) a soluble synthetic tetrapeptide Arg-Gly- 
Asp-Ser (RGDS; Pierschbacher, M.  D., and E.  Ruos- 
lahti,  1984, Nature  (Lond.),  309:30-33) representing a 
cell-binding determinant in the 75-kD fragment,  and 
(b) an antibody raised against the 33-kD fragment that 
binds specifically to that fragment.  Initial cell attach- 
ment to, and neurite extension upon, fibronectin and 
the two different fragments was evaluated in the pres- 
ence and absence of the two reagents. 
Attachment of both PNS and CNS cells to intact 
fibronectin was reduced in the presence of RGDS, the 
former more so than the latter.  In contrast,  the anti- 
body to the 33-kD fragment did not affect attachment 
of PNS cells to fibronectin, but significantly decreased 
attachment of CNS cells to the molecule. RGDS in- 
hibited attachment of both cell types to the 75-kD 
fragment to a greater degree than  it did attachment to 
the intact molecule. Cell interaction with the 33-kD 
fragment was not affected by RGDS. Reduction of neu- 
rite lengths (determined after 24 h of culture) by the 
domain-specific reagents paralleled the reduction in 
initial adhesion to each substratum.  Therefore, it ap- 
pears that (a) both PNS and CNS cells have receptors 
for each cell-binding domain of fibronectin,  (b) the 
receptor(s) for the two domains are distinct,  with at- 
tachment to the 33-kD fragment being independent of 
RGDS, and (c) the relative importance of each domain 
to cell interaction with intact fibronectin is different 
for CNS and PNS cells. 
N 
'EURONS encounter  extracellular  matrix  molecules 
during  critical  phases of embryonic differentiation 
and interact  with a  variety  of these molecules in 
vitro. Definition of the molecular bases of these interactions 
is likely to be of major importance in understanding  (a) ex- 
trinsic  influences on neuronal  differentiation,  (b) cell type- 
specific responses to extracellular  matrix components, and 
(c) mechanisms by which matrix molecules may support and 
possibly guide cell movements  and nerve fiber elongation 
(Letourneau, 1975). The extracellular  matrix glycoprotein fi- 
bronectin has been studied extensively  with respect to both 
its chemical structure and its interactions  with various types 
of cells (Furcht, 1983; Yamada, 1983; Hynes, 1986). Fibro- 
nectin mediates adhesion of many cells, including some neu- 
rons, to in vitro substrata, an interaction that may then lead to 
cell motility. Adhesion and motility of neuronal growth cones 
in response to fibronectin,  as well as other matrix molecules, 
can result in neurite elongation in vitro and possibly in vivo. 
Interactions  of embryonic chick peripheral  (PNS)  1 and 
central nervous system (CNS) cells with fibronectin and with 
proteolytic fragments  of the molecule were investigated  in 
earlier studies (Rogers et al., 1983, 1985). One of these frag- 
ments,  with an approximate  molecular mass of 75 kD, has 
been described by other laboratories and contains  a  cell- 
binding  domain  (Pierschbacher et al.,  1981; Hayashi  and 
Yamada,  1983) with a critical three amino acid sequence, 
1. Abbreviations used in this paper: CNS, central nervous system;  DRG, 
dorsal root ganglia; HSPG, heparan sulfate proteoglycen;  PNS, peripheral 
nervous system;  SC, spinal cord. 
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Yamada and Kennedy, 1984). This sequence is involved in 
binding of fibronectin to a specific set of cell surface glyco- 
proteins (Akiyama et al., 1985; Horwitz et al., 1985). A sec- 
ond cell-binding fragment, with an approximate molecular 
mass of 33 kD, was isolated and purified by virtue of its abil- 
ity to bind to heparin (Smith and Furcht,  1982; McCarthy 
et al.,  1986). It is located near the carboxyl terminus of 
fibronectin. Recently, other laboratories have described cell 
interactions with a  heparin-binding domain of fibronectin 
(Izzard et al., 1986; Woods et al., 1986), but neither the cell- 
binding constituent of the fragment, nor the cell surface 
receptor for this constituent have yet been adequately defined. 
Cells from the PNS attached to and extended neurites on 
intact fibronectin and both the 33- and 75-kD  fragments. 
CNS cells attached to and extended neurites on the 33-kD 
heparin-binding fragment, but initial interactions of these 
cells with the 75-kD fragment and with intact fibronectin 
were not sustained.. Specifically, CNS neurons initiated neu- 
rites on the 75-kD fragment, but the neurites retracted and 
the cells detached after •24  h in culture. Intact fibronectin 
supported attachment of  fewer CNS cells than PNS cells, and 
neurites were not observed in these CNS cultures. These ob- 
servations of cell behavior suggested that (a) the two cell- 
binding  domains  of fibronectin have distinct interactions 
with neuronal surfaces, (b) CNS and PNS cells have qualita- 
tive and/or quantitative differences in their binding sites for 
fibronectin, and (c) cells may have multiple interactions with 
fibronectin that are specific to cell type and/or activity. 
These hypotheses raised additional questions which are 
addressed in the present study. First, can the difference(s) 
between the two fragments be further defined with respect 
to their interactions with cell surfaces? Although fibronectin 
receptors have been isolated from several cell types (Horwitz 
et al., 1985; Pytela et al., 1985; Akiyama et al., 1986; Uru- 
shihara and Yamada,  1986),  receptor isolation would be a 
difficult task with heterogeneous primary neuronal cultures. 
Fortunately, alternative approaches,  such as using proteo- 
lytic fragments with adhesion-promoting activity, may also 
provide insights. Second, how do the interactions between 
neurons and isolated fibronectin fragments relate to neuronal 
interaction with the intact molecule? Although nervous sys- 
tem cells can interact with two distinct fibronectin domains, 
previous studies do not define the significance of each do- 
main to neuronal interaction with intact fibronectin during 
cell attachment and/or neurite extension. 
The development of reagents that interfere selectively with 
cell adhesion to cell-binding domains has permitted more re- 
fined approaches to the above questions. Attachment of some 
cells to fibronectin can be competitively inhibited by the syn- 
thetic tetrapeptide RGDS, representing a cell-binding deter- 
minant in the 75-kD fragment of fibronectin (Pierschbacher 
and Ruoslahti, 1984a; Yamada and Kennedy, 1984). To test 
the significance of the 33-Kd heparin-binding domain to cell 
interaction with fibroneedn, a polyclonal antibody was raised 
against the 33-kD  fragment.  These two reagents and the 
highly purified fibronectin fragments were used in a variety 
of in vitro experiments to further probe interactions of ner- 
vous system cell interaction with fibronectin.  The results 
reinforce the notion that different  types of  cells interact selec- 
tively with multiple cell-binding domains of extracellular 
matrix molecules. 
Materials and Methods 
Reagents 
Human plasma fibroneetin and fibronectin fragments were prepared as de- 
scribed.previously (Smith and Fureht,  1982;  Smith et al.,  1982;  Rogers et 
al.,  1985;  McCarthy et al.,  1986).  In the present study, only the tyro flag- 
ments that mediate cell-substratum binding were used.  Briefly, a  75-kD 
fragment was isolated by trypsinization of fibronectin, followed by mono- 
clonal antibody  180-8  affinity chromatography  (McCarthy et al.,  1986). 
This fragment does not bind heparin or gelatin. A 33-kD beparin-binding 
fragment from the carboxyl terminal region of fibronectin was purified from 
a 33/66 kD complex (Rogers et al., 1985; McCarthy et al., 1986) by affinity 
chromatography on monoclonal antibody 2-8  (Smith and Furcht,  1982; 
McCarthy et al.,  1986). The 66-kD fragment binds the antibody, while the 
33-kD peptide does not. 
Laminin was isolated from mouse EHS tumor basement membrane as 
described previously (Palm and Furcht,  1983). 
Antiserum was raised against the 33-kD fibronectin fragment by injection 
of the  emulsified  fragment  into  New  Zealand  white  rabbits,  and  then 
purified on a 33-kD fragment affinity column. This antibody does not cross- 
react with any of the other fibronectin fragments as analyzed by immunobtot 
analysis. 
The synthetic tetrapeptide Arg-Gly-Asp-Ser (RGDS), representing a cell- 
binding determinant of fibronectin, was purchased from Peninsula Labora- 
tories, Inc., Belmont, CA. The hybridoma producing monoclonal antibody 
A2B5, raised against a chick retinal ganglioside (Eisenbarth et al.,  1979), 
was purchased from American Type Culture Collection, Roekville, MD. 
Preparation of  Substrata 
All proteins were diluted in 0.05 M carbonate buffer (pH 9.6). Concentra- 
tions for each experiment are indicated in the figure legends and discussed 
in Results. Diluted proteins were applied to 24-well plates (Costar, Cam- 
bridge, MA) in 300-gl aliquots and incubated overnight at 37~  The wells 
were then rinsed twice with PBS, incubated for 2-3 h with BSA (5 mg/ml, 
fatty-acid free; Boehringer Mannheim Bioehemicals, Indianapolis, IN) to 
reduce nonspecific cell attachment to plastic, and rinsed again with PBS be- 
fore addition of cells.  Approximately  10-25% of applied protein binds to 
plastic under the conditions described (Rogers et al.,  1985). 
Adhesion Assays 
Dorsal root ganglia (DRGs) or spinal cords (SCs) were dissected from chick 
embryos at 10 or 6 d of incubation, respectively. Cells were dissociated with 
trypsin (0.25%  Bactotrypsin; Difco Laboratories,  Inc.,  Detroit, MI) and 
plated at 20,000 cells per well in serum-free Ham's F14 supplemented with 
insulin (5 gg/ml,  Sigma Chemical Co.,  St.  Louis, MO), transferrin (100 
gg/ml),  and  sodium  selenite  (30  nM).  DRG  cultures  were  also  sup- 
plemented with 10 ng/ml nerve growth factor (7S NGF; HyClone Laborato- 
ries, Logan, UT). Optimal times for adhesion assays were determined by 
trial and error for each cell type. At 2 h of incubation DRG cells attached 
to the fibronectin and laminin substrata, but not to BSA. For SC cells it was 
necessary to increase the assay time to 4  h to obtain approximately equal 
attachment to all of the coating proteins. After incubation at 37~  the wells 
were rinsed twice with warm PBS to remove nonadherent cells, and the re- 
maining cells were fixed with 2% glutaraldehyde. Cells were stained with 
Dif-Quick (Scientific Products) and counted with an Image System IV (Op- 
tomax, Hollis, NH) attached to an Olympus IMT-2 inverted microscope and 
to a computer (Apple Computer, Inc., Cupertino, CA) for statistical analysis 
of data. Duplicate wells were prepared for each experimental condition, and 
the average number of cells per field was computed from counts of cells in 
five fields per well. 
When the synthetic tetrapeptide RGDS was used in adhesion assays, it 
was added to wells along with the cell suspension. For assays with the 33-kD 
fragment antibody, substrata were preincubated with a lO-fold excess of anti- 
body for 2 h, the wells were rinsed, and additional antibody was added to 
the cell suspension, 
Neurite Extension Assays 
DRG cells were allowed to attach to the various substrata for "~16 h, by 
which time many neurons had extended short neurites. RGDS or antibody 
to the 33-kD fragment was then added to the cultures. Neurite elongation 
was allowed to proceed for an additional 8 h and the cells were then fixed 
The Journal of Cell Biology, Volume 105,  1987  1436 with 2 % glutaraldehyde. Neurites were measured with a digitizing tablet at- 
tached to the image analysis system described above. 
Immunocytochemistry 
To stain cells with the A2B5 monoclonal antibody, adhesion assays were 
performed with cells cultured on coverslips that had been treated with the 
substratum proteins and placed in 24-well plates. Living cells were treated 
with A2B5 in PBS containing 5 mg/ml BSA (1:10 dilution of A2B5 ascites 
fluid) for 15 min. The coverslips were then rinsed with PBS, fixed with 4% 
paraformaldehyde, rinsed, treated with rhodamine isothiocyanate goat anti- 
mouse IgG (1:100), rinsed again, and mounted on slides. Cells were exam- 
ined with a Zeiss IM35 microscope equipped with fluorescence optics. 
Results 
Characterization  of  Fibronectin Fragments 
The two fibronectin fragments used in this study have been 
described in detail in a  recent report by McCarthy et al. 
(1986).  The 75- and 33-kD fragments are distinct by elec- 
trophoretic and immunochemical criteria, have different li- 
gand-binding properties, and can mediate different types of 
cell behavior. Location of these fragments in the fibronectin 
molecule is shown in Fig.  1.  Relevant to the present study 
is the ability of the 33-kD fragment to bind heparin,  and 
the location of a cell-binding determinant, Arg-Gly-Asp-Ser 
(RGDS), in the 75-kD fragment. 
Domain-specific  Inhibition of  Cell Adhesion 
to Fibronectin Substrata 
The absolute number of cells that attached to any given sub- 
stratum  varied  as  experiments  were  repeated.  However, 
within each experiment the number of cells that attached to 
control substrata (i.e., in the absence of competing reagents) 
was relatively consistent. These values are presented in the 
figure legends. For each substratum, counts of cells attached 
in the presence of competing reagents were compared with 
control values, and the relative values expressed as percent- 
age of control cells attached (mean number of experimental 
cells/mean number of control cells  ￿  100  +  SEM). 
Concentrations of the substratum proteins in the coating 
solutions were  1  ￿  10  -7 M  fibronectin and the two frag- 
ments (20 gg/ml fibronectin, 7 IJg/ml 75-kD fragment, and 
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Figure  1.  A  model  of the  fibronectin molecule  (adopted  from 
McCarthy et al., 1986) illustrating the positions of the two proteo- 
lytic fragments used in this study, as well as other biologically ac- 
tive domains (Furcht,  1983). At the amino terminus of the mole- 
cule, a 27-kD fragment binds staph, heparin (weak activity), and 
fibrin. Collagen-binding activity resides in domain II, in a 46-kD 
fragment.  The 75-kD fragment,  first described by Hayashi and 
Yamada (1983), contains a free sulfhydryl (domain III) and a cell- 
binding determinant  (Arg-Gly-Asp-Ser) in  domain IV  (hatched 
area; Pierschbacher and Ruoslahti,  1984a). The 33-kD heparin- 
binding fragment (domain V) also binds to cell surfaces, as de- 
scribed in detail in the text. Domain Via represents a free sulf- 
hydryl, and domain VIb, at the carboxyl terminus of fibronectin, 
contains interchain disulfide bonds. 
3 ~tg/ml 33-kD fragment) for most experiments. In addition, 
some experiments were performed using 5  x  10  -7 M 75- and 
33-kD fragments. Since cell attachment did not differ signifi- 
cantly (by t test analysis) among experiments using different 
coating concentrations, values are presented for one concen- 
tration of each extraceUular matrix protein in each experi- 
ment. Those concentrations are indicated in the figure leg- 
ends. Laminin was diluted to 2  x  10  -s M (20 gg/ml). Lam- 
inin-treated substrata  provided a  positive control,  as  cell 
binding  to this  glycoprotein has  not been reported to be 
RGDS-dependent. 
The synthetic tetrapeptide RGDS was used at a concentra- 
tion of 10  -3  M  (0.44 mg/ml)  in all experiments reported. 
Because inhibition of cell attachment was incomplete at this 
concentration, repeated attempts were made to increase inhi- 
bition of attachment with a  higher dose of RGDS and/or 
lower concentrations of substratum proteins. Although 2  x 
10  -3 M  RGDS (1 mg/ml) inhibits attachment of normal rat 
kidney (NRK) cells (Pierschbacher and Ruoslahti,  1984b) 
and spreading of baby hamster kidney (BHK) and B16-F10 
melanoma cells (Humphries et al.,  1986), increased inhibi- 
tion was not observed in the primary cultures used in the 
present  study.  In  addition,  lowering the  concentration of 
fibronectin to 5  x  10  -9 M did not increase inhibition at any 
dose of RGDS. Possible explanations for this incomplete in- 
hibition will be discussed below. 
Attachment to Nonfibronectin Substrata.  Laminin was 
used as a control extracellular matrix glycoprotein to ensure 
that effects of the competing reagents were not due to toxicity 
or to other nonspecific events. Neither RGDS nor the 33- 
kD  antibody had  significant effects on cell attachment to 
laminin. 
For adhesion assays, wells coated with fibronectin, the two 
fragments, or laminin were subsequently treated with BSA 
to prevent nonspecific binding of cells to tissue culture plas- 
tic. In all experiments reported, a negligible number of cells 
attached to BSA-treated wells. This prompted the assumption 
that the cell attachment observed was in response to the ex- 
tracellular matrix proteins adsorbed to plastic. 
Attachment to Fibronectin Fragments. Inhibition of cell 
attachment to the two fibronectin fragments by RGDS and 
the 33-kD fragment antibody occurred in a domain-specific 
manner. Attachment of both DRG and SC cells to the 75-kD 
fragment was reduced by RGDS (Fig. 2). While this inhibi- 
tion is somewhat greater than that observed for attachment 
to fibronectin, these differences are not statistically signifi- 
cant.  In  contrast,  the  33-kD  fragment  antibody  did  not 
significantly affect cell attachment to the 75-kD  fragment 
(Fig. 3). The small effect observed is probably nonspecific, 
as there is a similar effect of the antibody on cell attachment 
to laminin. 
Attachment of DRG and SC cells to the 33-kD fragment 
was reduced to 35-40%  of control values by the antibody 
raised against the  33-kD fragment (Fig.  3).  Significantly, 
RGDS did not affect interaction of either cell type with this 
fragment (Fig. 2; P  <  0.01). 
Attachment to Intact Fibronectin. RGDS reduced the 
number of both DRG and SC cells attached to intact fibro- 
nectin (Fig.  2).  For DRG cells the percentage of cells at- 
tached to fibronectin in the presence of RGDS was signifi- 
cantly smaller than that for attachment to laminin or to the 
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Figure 2. Effect of the fibronectin tetrapeptide RGDS on attachment 
of DRG and SC cells to fibronectin substrata and laminin.  Cells 
were plated in tissue culture wells treated with fibronectin (FN), the 
two FN fragments (75 and 33 kD) or laminin (LAM), in the pres- 
ence (experimental)  and absence  (controls)  of RGDS (10  -3 M). 
Concentrations of proteins in the coating solutions were 1 x  10  -7 
M for FN and the two fragments and 2 x  10  -8 M for LAM. After 
2 (DRG cells) or 4 (SC cells) h of incubation,  nonadherent cells 
were removed by rinsing and the remaining cells fixed and counted. 
The percentage of cells  attached  in the  presence  of RGDS (ex- 
perimental values) was expressed as a percentage of control values 
(without RGDS), calculated as the number of experimental cells 
divided by the number of control cells  x  100. Error bars =  SEM. 
Means  of the absolute  numbers  of control  cells  attached  (mean 
number of cells per field +  SEM):  (DRG cells) FN =  79 +  24; 
75 kD = 66 +  15; 33 kD = 47 +  10; LAM =  51 +  15; (SC cells) 
FN =20+9;75kD=30+  11;33kD=22  +6;LAM  =92 
+  46. 
33-kD fragment (P < 0.05). There was less inhibition of SC 
cell  attachment  to  fibronectin  by  RGDS,  and  this  value 
(76.7%  control cells attached) falls between values for SC 
cell attachment to the 75- and 33-kD fragments (i.e., it is not 
signifcantly different from either, P > 0.05 for each compar- 
ison). While the difference between the effects of RGDS on 
SC and DRG attachment to fibronectin was not quite statisti- 
cally significant (P =  0.156),  a significant difference might 
be revealed with a larger sample size (Cohen,  1977). 
In contrast to RGDS, the 33-kD fragment antibody strik- 
ingly inhibited SC cell attachment to fibronectin, reducing 
the number to <50% of control ceils attached (Fig. 3). This 
value is not different statistically from the percentage of SC 
cells attached to the 33-kD fragment in the presence of anti- 
body (P > 0.05). Attachment of DRG cells to fibronectin, on 
the other hand, was not affected by the 33-kD antibody. This 
difference in cell interaction with fibronectin is emphasized 
by the fact that attachment of both DRG and SC cells to the 
33-kD  fragment  was  similarly  reduced  by  the  antibody. 
These observations suggest that (a) DRG and SC cells inter- 
act differently with these two cell-binding domains of intact 
fibronectin, (b) the 33-kD heparin-binding domain is more 
important to SC than to DRG cell attachment to the intact 
molecule, and (c) the cell-binding determinant in the 33-kD 
domain is accessible to cells in intact fibronectin. 
To investigate further whether cells can use both the 33- 
and  75-kD domains  in  intact  fibronectin,  or interact with 
them in an alternate manner, an additional experiment was 
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Figure 3. Attachment of DRG and SC ceils in the presence of poly- 
clonal antibody raised against the 33-kD heparin-binding fragment. 
Wells coated with each substratum protein were preincubated with 
a lO-fold  excess of antibody before addition of cells, and additional 
antibody was added to the cell suspension. Concentrations of pro- 
teins  in the coating  solutions  were:  FN,  1  x  10  -7 M;  75- and 
33-kD fragments, 5 x  10  -5 M; LAM, 2  x  10  -8 M. Attached cells 
were fixed and counted as described for Fig. 2. Means of the abso- 
lute numbers of control cells attached (mean number of cells per 
field +  SEM): (DRG cells) FN  =  60 +  8; 75 kD =  82  +  4; 33 
kD =  51  +  10; LAM =  45  +  27; (SC cells) FN =  40 +  21; 75 
kD  =  17  +  3; 33kD  =  33  +  3;LAM  =  96  +  39. 
performed. Substrata coated with fibronectin (1  x  10  -7 and 
2.5  x  10  -8 M) were treated with the 33-kD fragment anti- 
body as described above and RGDS was added to the DRG 
cell suspension in some of the wells. When combined, these 
two reagents have an additive effect, reducing the number of 
cells attached to 20% of control values in one experiment, 
and to 37 % in another experiment (data not shown). This in- 
dicates that DRG cells can interact with both the 33- and 75- 
kD domains in intact fibronectin, and supports the possibil- 
ity that cell interaction with the 33-kD domain may at least 
partially account for the incomplete inhibition of cell attach- 
ment by RGDS. 
Demonstration of the Presence of  Neurons 
in Adhesion Assays 
A potential problem in interpretation of the adhesion assays 
described above is the heterogeneity of the cell populations. 
In assays that are only a few hours in length it is impossible 
to determine accurately, at least by morphological criteria, 
what cell types are present. During this period nonneuronal 
cells may not spread, and, consequently, they may resemble 
phase-bright neuronal somata. Also, most neurons have not 
yet begun to extend neurites and cannot, therefore, be identi- 
fied on this basis. The monoclonal antibody A2B5 (Eisen- 
barth et al., 1979) recognizes a neuronal cell surface ganglio- 
side and was used to identify neurons in DRG cell adhesion 
assays. (This antibody was not useful in differentiating cell 
types in SC cultures, as it also recognizes a class of CNS glia 
(Schnitzer and Schachner,  1982). 
In cultures of DRG cells, A2B5 stains 3 % or fewer cells 
that are nonneuronal in appearance (i.e., flattened or spread). 
After staining cultures with the antibody, the percentage of 
fluorescent cells was determined for each experimental con- 
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At least 100 cells per condition were counted. Both A2B5- 
positive cells and  cells with nonneuronal morphology at- 
tached to the three fibronectin substrata in 2-h adhesion as- 
says (Fig.  4).  The percentage of neurons in the heteroge- 
neous  cell populations plated on fibronectin and  the two 
fragments was nearly identical (•33%),  and demonstrated 
that neurons participate in the interactions described above. 
Thus, differential attachment of neuronal and nonneuronal 
populations  to  the  three  substrata  was  not  observed,  fit 
should be noted that this proportion of neurons approximates 
that  found in  intact dorsal root ganglia at this  embryonic 
stage.)  Addition  of RGDS  did  not  significantly alter the 
proportion of neurons attached to each substratum, indicat- 
ing that two major subpopulations, at least in these cultures, 
interact with the RGDS determinant of fibronectin to a simi- 
lar extent. There was a reduction in the percentage of neu- 
rons attached to the three substrata in the presence of 33-kD 
fragment antibody, but the significance of this observation is 
not yet clear. 
Domain-specific Inhibition of  Neurite Extension 
on Fibronectin Substrata 
Measurements of neurite length were obtained for DRG neu- 
rons only, as SC neurons extend neurites on fibronectin and 
Table L Effect of  RGDS on DRG Neurite Lengths 
Average neurite length 
Substratum  Control  + RGDS  P~ 
ltm +  SEM*  ltm +  SEM* 
(No.  neurons)  (No.  neurons) 
Fibronectin  280  +  34  163  4-  34  <0.05 
(10)  (10) 
75 kD  279  4-  23  166  +  17  <0.001 
(19)  (19) 
33 kD  271  4.  22  237  •  42  NS 
(12)  (12) 
* Neurite lengths represent the average total neurite length per neuron, mea- 
sured after 24 h of culture. The values reported are from experiments using 
10  -~ M  and 5  ￿  10  -7 M  75- and 33-kD fragments to coat substrata. 
Significance levels for two sample t tests comparing neurite lengths in the 
presence and absence of antibody. The differences in neurite lengths on fibro- 
nectin and the 75-kD fragment are significant. 
the 75-kD fragment only transiently. Neurite elongation by 
DRG neurons paralleled initial cell adhesion to the substrata, 
in terms of (a) the domain-specific effects of RGDS and the 
33-kD fragment antibody, and (b) the relative impact of each 
reagent on DRG neurite extension on intact fibronectin. The 
values reported in Tables I and II represent mean lengths of 
all neurites extended by each neuron sampled. 
Neurites elongated in response to both high and low coat- 
ing concentrations of the substratum proteins (as discussed 
in the section on adhesion assays),  but they were shorter 
when the lower concentration was used.  Therefore, values 
are reported for experiments using coating concentrations 
that yielded similar neurite lengths under control conditions 
(see Tables). Addition of RGDS to cultures at 16 h resulted 
in  significantly shorter neurites on  substrata  treated with 
fibronectin and the 75-kD fragment (Table I). The reduction 
in neurite length by RGDS was consistent for these two sub- 
strata,  regardless of concentration of the  substratum  pro- 
teins. During the 8 h of culture after adding RGDS, neurite 
elongation appeared to be slowed rather than halted, judged by 
Figure 4.  Dorsal root ganglion cells plated on fibronectin for 2  h. 
(a) Both flattened cells (small arrows) and phase-bright cells that 
appear to be neurons (large arrows) have attached to the substra- 
tum. Phase optics. Bar, 50 ~tm. (b) Same cells as in a, viewed with 
fluorescence optics. Cultures have been stained with the neuron- 
specific monoclonal antibody A2B5, confirming the identity of the 
nonflattened cells in a as neurons. 
Table II. Effect of  33-kD Fragment Antibody on 
DRG Neurite Lengths 
Average neurite length 
+33-kD 
Substratum  Control  Antibody  P* 
ltm  +  SEM*  ltm  +  SEM* 
(No.  neurons)  (No.  neurons) 
Fibronectin  247  +  19  242  +  19  NS 
(40)  (40) 
75  kD  357  +  42  263  +  23  0.057 
(24)  (24) 
33  kD  249  +  20  104  +  11  <0.0001 
(30)  (30) 
* Neuritr  lengths represent the average total neurite length per neuron, mea- 
sured after 24 h of culture. The values reported are from experiments using 
10  -7 M  fibronectin and 5  x  10  -7 M  75- and 33-kD fragments to coat sub- 
strata. 
~: Significance levels for two sample t tests comparing neurite lengths in the 
presence and absence of antibody.  The difference in neurite lengths on the 
33-kD fragment is highly significant. 
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tourneau et al., 1986). Neurite formation on the 33-kD frag- 
ment was not significantly affected by RGDS. This indicates 
that binding of RGDS to growth cone surfaces does not, in 
itself, slow neurite elongation, but that RGDS blocks interac- 
tion with a specific determinant of fibronectin. 
Antibody against the 33-kD fragment had no effect  on neu- 
rite elongation on intact fibronectin, but caused a  highly 
significant reduction of length on the 33-kD fragment (Table 
II).  The reduction in average neurite length on the 75-kD 
fragment is significant (P = 0.057), but may be a nonspecific 
effect, as a slight inhibition of initial attachment to the 75-kD 
fragment and to laminin was also observed (Fig.  3).  Al- 
though neurite elongation occurs on both fibronectin frag- 
ments, these experiments suggest that DRG growth cones, 
like DRG cell bodies, interact preferentially with the fibro- 
nectin molecule via the RGDS determinant. 
Discussion 
Complex interactions of  cells with components of extracellu- 
lar matrices may be mediated by cell binding to specific mo- 
lecular domains. In previous studies, it was demonstrated 
that CNS and PNS cells interact differently with the fibro- 
nectin molecule (Rogers et al., 1983, 1985). Both DRG cells 
from the PNS, and SC cells from the CNS adhered to a 33- 
kD heparin-binding fragment, and neurons in the cell popu- 
lations extended neurites in response to it. Intact fibronectin 
and  a  75-kD  cell-binding  fragment  supported  these  re- 
sponses by PNS cells, but interactions of CNS cells with 
these proteins were not sustained. However, the mechanisms 
underlying these differential responses were not clear. The 
experiments reported here demonstrate that (a) distinct mo- 
lecular mechanisms are responsible for cell interactions with 
the two regions of fibronectin, and (b)  the relative impor- 
tance of each domain to interaction with intact fibronectin is 
different for the two cell populations. 
The synthetic tetrapeptide RGDS represents a cell-binding 
determinant in a  75-kD fragment of fibronectin (Piersch- 
bather and Ruoslahti, 1984a, b). When added to cell suspen- 
sion, RGDS binds to a cell surface receptor and inhibits ceil 
interaction with that sequence,  if present,  in substratum- 
bound molecules. Experiments in which RGDS reduced cell 
attachment to intact fibronectin and to the 75-kD fibronectin 
fragment indicate that both SC and DRG cells have receptors 
for RGDS and that they can bind to this determinant in the 
substratum-bound proteins. Further, this interaction is dis- 
tinct from cell attachment to the 33-kD domain, as RGDS 
had no effect on attachment to the 33-kD fragment. Some- 
what less RGDS inhibition of SC cell adhesion to fibronectin 
and the 75-kD fragment, compared with DRG cell adhesion, 
was observed, and might partially explain weaker interaction 
of SC cells with intact fibronectin. The defect(s) in this inter- 
action is not limited to short term adhesion assays, as neurite 
extension in response to fibronectin and the 75-kD fragment 
is also defective (Rogers et al., 1985). RGDS-mediated bind- 
ing to fibronectin may be critical for stable cell interaction 
with the molecule, and SC cells may have insufficient num- 
bers of RGDS receptors and/or may lack additional surface 
constituents necessary for stable interaction. Interestingly, 
SC cells stain with the CSAT monoclonal antibody, which 
recognizes a receptor for fibronectin and laminin (Horwitz 
et al.,  1985),  but this staining is less intense than CSAT 
staining of DRG cells (Letourneau, E, unpublished observa- 
tions). 
Inhibition by RGDS of cell attachment to fibronectin sub- 
strata was incomplete in all experiments, and several poten- 
tial explanations for this observation should be considered. 
First, binding of RGDS to cell surfaces appears to be of low 
affinity (Yamada,  1983; Akiyama et al., 1985, 1986), which 
might allow some cells to make adhesive contacts with the 
substratum that are stable to the rinses used in the adhesion 
assays.  Second, soluble RGDS may not be able to compete 
effectively with more stable interactions of cells with sub- 
stratum-bound fibronectin peptides. Stability of these inter- 
actions might be imparted by sequences adjacent to RGDS, 
obviously not present in the soluble,  isolated tetrapeptide 
(Ruoslahti et al.,  1985). Third,  incomplete inhibition by 
RGDS might be explained simply by alternative cell interac- 
tions with non-RGDS sites in intact fibronectin and possibly 
in  the  75-kD  fragment (Urushihara  and Yamada,  1986). 
While each of  these phenomena may contribute to the incom- 
plete inhibition observed, the heterogeneous nature of the 
primary cultures used in this study is also likely to be a criti- 
cal factor. Studies using homogeneous cell lines to evaluate 
the effects of RGDS on attachment to fibronectin have ob- 
tained complete, or nearly complete inhibition of attachment 
(Pierschbacher and Ruoslahti, 1984b; Yamada and Kennedy, 
1984; Akeson and Warren, 1986; McCarthy et al., 1986). In 
fact, complete inhibition of cell attachment was  observed 
with doses of RGDS identical to those used in this study 
(Pierschbacher  and  Ruoslahti,  1984; Humphries  et  al., 
1986). In heterogeneous DRG and SC cultures, different cell 
types (i.e.,  neurons,  fibroblasts,  glia) may have different 
affinities for RGDS, may bind preferentially to non-RGDS 
binding sites in the substratum-bound proteins, and/or may 
produce their own attachment factors. It is important to note, 
however, that neurons (identified as A2B5-positive cells) in 
the DRG populations were shown to be affected by RGDS to 
the same extent as the population as a whole. Further work 
is necessary to more precisely characterize interactions, in- 
dependent of RGDS, of nonneuronal nervous system cells 
with fibronectin. 
The antibody to the 33-kD fragment interfered with DRG 
and SC cell binding to that fragment, but had no effect on 
cell attachment to the 75-kD  fragment. The location of the 
site in the 33-kD fragment with which nervous sytem cells 
interact is not yet clear, but it appears to be separate from 
an alternatively spliced cell-binding site in this region of 
fibronectin, described recently by Humphries et al. (1986). 
The 33-kD fragment antibody had strikingly different effects 
on DRG and SC cell attachment to intact fibronectin. Com- 
pared with a negligible effect on attachment of DRG cells, 
the antibody reduced SC cell adhesion to intact fibronectin 
by an average of 55% (in contrast to only 24% inhibition by 
RGDS). This experiment demonstrates preferential adhesion 
of SC cells to the 33-kD domain of fibronectin, as was sug- 
gested previously (Rogers et al., 1985). However, the ques- 
tion then arises as to why SC cells have stable interactions 
(i.e., neurite extension) with the 33-kD fragment of  fibronec- 
tin but not with the intact fibronectin molecule. This question 
will be difficult to address until more is known about (a) ex- 
posure of the 33-kD domain during conformational altera- 
tions of fibronectin under various conditions of binding to in 
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1983),  and  (b)  possible  remodeling of substratum-bound 
fibronectin by  cells  in  the  process  of attachment and/or 
migration. It seems likely that multivalent interactions with 
fibronectin are complex (see Decker et al., 1984), involving 
even more cell-binding determinants in the molecule and/or 
cell surface constituents than have been evaluated to date. 
The identity of cell surface receptors for fibronectin is still 
under active investigation. Receptors have been isolated by 
several  groups  using  a  variety  of methods  (Brown  and 
Juliano, 1985; Hasegawa et al., 1985; Horwitz et al., 1985; 
Pytela et al.,  1985; Akiyama et al.,  1986; Urushihara and 
Yamada, 1986). Most of these studies have identified a com- 
plex of three glycoproteins ranging in apparent molecular 
size from 120 to 155 kD, referred to as a  140-kD complex, 
which apparently interacts with the RGDS sequence of fibro- 
nectin (Akiyama et al., 1986). The CSAT monoclonal anti- 
body recognizes this 140-kD complex (Knudsen et al., 1985) 
and also  interacts with neuronal  surfaces  (Bozyczko and 
Horwitz,  1986).  Therefore, this complex of glycoproteins 
may be involved in RGDS-mediated neuronal adhesion to 
fibronectin. However, at least one additional glycoprotein 
class  appears  to be  involved in cell-fibronectin adhesion 
(Urushihara and Yamada,  1986); gangliosides (Yamada  et 
al., 1983) and proteoglycans (Perkins et al., 1979) are fibro- 
nectin receptor candidates as well. 
Cell surface heparan sulfate proteoglycan (HSPG) is an 
obvious possibility as  a  receptor for the  33-kD  heparin- 
binding domain of fibronectin (Laterra et al., 1983; Woods 
et al.,  1984). Evidence demonstrating that the 33-kD frag- 
ment binds HSPG (McCarthy, J. B., unpublished observa- 
tions) is highly suggestive,  but does not in itself prove that 
cell surface HSPG binds to the fibronectin domain. Two re- 
cent studies show that fibroblasts (Izzard et al., 1986; Woods 
et al.,  1986) require both the cell-binding and a  heparin- 
binding domain to exhibit a  spreading response complete 
with focal contacts and stress fibers. Although direct evi- 
dence is lacking that HSPG is involved in these responses, 
the heparan sulfate binding protein, platelet factor 4, in com- 
bination with the cell-binding fibronectin fragment, elicits 
the same complete spreading response as does intact tibro- 
nectin (lzTard et al., 1986). Some neurons express HSPG on 
their surfaces (Ratner et al., 1985) and may use the molecule 
to adhere to in vitro substrata (Cole et al.,  1985; Matthew 
et al., 1985; Ratner et al., 1985; Schubert and LaCorbiere, 
1985;  Tobey et al.,  1985). It is important that the conse- 
quences  for  cytoskeletal organization  of cell  binding  to 
fibronectin via HSPG appear to be very different from those 
resulting from adhesion via the 140-kD complex mediated by 
RGDS  (Izzard  et  al.,  1985). It is  plausible  that HSPG- 
mediated cell binding to fibronectin, or other matrix mole- 
cules, stabilizes cells (some cells attach to, but do not migrate 
on  the  33-kD  fragment [McCarthy et al.,  1986]) and/or 
modulates interaction with the other cell-binding determi- 
nant(s). Similar mechanisms for modulation by HSPG of  cell 
adhesion, shape, and/or locomotion might operate for fibro- 
blasts, neuronal cell bodies, and neuronal growth cones. But 
additional tools, such as antibodies that block the HSPG- 
binding capacity of fibronectin or recognize neuronal cell 
surface HSPG, are needed to evaluate potential roles of this 
proteoglycan more precisely. 
Adhesion and motility of DRG growth cones on substrata 
treated with fibronectin and the two fibronectin fragments 
paralleled the responses of neuronal cell bodies during initial 
adhesion. Shorter neurite lengths on fibronectin and the 75- 
kD fragment in the presence of RGDS were due to slower 
rates of growth cone migration, rather than complete cessa- 
tion of activity (Letourneau et al., 1986). Continued growth 
cone activity might be explained by low affinity binding of 
RGDS to growth cone surfaces, or to alternative growth cone 
adhesion to the 33-kD heparin-binding domain (in the case 
of migration on intact fibronectin). The results indicate that 
growth cones of DRG neurons can migrate in response to 
fibronectin via at least two separate mechanisms,  one of 
which does not involve the RGDS determinant. However, in- 
teraction with the 33-kD domain does not appear to be essen- 
tial for growth cone migration on intact fibronectin, as in the 
results of assays for initial adhesion of DRG cell bodies. 
In  conclusion,  several  specific questions raised by our 
previous work have been at least partially answered in this 
report. First, we have demonstrated that attachment of CNS 
and PNS cells to the 75-kD fragment of fibronectin involves 
a cell surface receptor for the RGDS sequence, while attach- 
ment to the 33-kD heparin-binding fragment is independent 
of RGDS.  Second, the role that each cell-binding domain 
plays in cell attachment to the intact fibronectin molecule can 
vary with the cell population. Specifically, DRG cells can in- 
teract with fibronectin via the RGDS determinant when the 
33-kD domain is blocked, while binding of SC cells to intact 
fibronectin depends to a greater degree on interaction with 
the 33-kD domain. In addition, it appears that nervous sys- 
tem cells can have multivalent interactions with fibronectin 
and that these interactions may involve a number of binding 
determinants in fibronectin and/or several cell surface recep- 
tors for the molecule. 
It will now be important to test the significance of the two 
cell-binding  domains  of  fibronectin  (a)  to  growth  cone 
migration through complex extracellular matrices and (b) 
during embryonic differentiation of PNS neurons. Popula- 
tions of neural crest cells can use fibronectin as a substratum 
for migration (Weston,  1980; Rovasio et al., 1983; Bronner- 
Fraser, 1985) and it appears that differentiation of these cells 
into a variety of phenotypes can also be influenced by ex- 
posure to the molecule (Loring et al., 1982). An intriguing 
possibility is that differentiation of individual neural crest 
cells into subpopulations of PNS cells may be mediated by 
specific fibronectin cell-binding domains. As a  result, the 
ability of PNS cells to interact in a stable manner with two 
domains of fibronectin might reflect their developmental his- 
tory. Comparisons between neural crest-derived and non- 
neural crest-derived cells (such as those from the CNS) may 
provide clues to the significance of multivalent cell-extracel- 
lular matrix interactions. 
The authors wish to thank Susan Alexander,  Joy Bennin, and Scott Hagen 
for their assistance with various technical aspects of this study. Ms. Kathy 
Hsi and Dr.  Dorothy  Pathak (Family, Community,  and Emergency  Medi- 
cine, University of New Mexico) are gratefully acknowledged for perform- 
ing and interpreting the statistical  analyses. 
This research was  supported by National Institutes of Health grants 
HD19950  (P.  C.  Letourneau), NS23360  (S.  L.  Rogers),  CA39510 (J. B. 
McCarthy), and CA21463 and CA29995 (L. T. Furcht) and by grants from 
the National Science Foundation (PCM8203855)  and the Spinal Cord Soci- 
Rogers et al. Nervous System Cell Interaction with Fibronectin  1441 ety (t'. C, Letourneau). L. T. Furcht is Stone Professor of Pathology at the 
University of Minnesota. 
Received for publication 28 October 1986, and in revised form 27 April 1987. 
References 
Akeson, R., and S. L. Warren. 1986. PCl2 adhesion and neurite formation on 
selected substrates are inhibited by some glycosaminoglycans and a fibro- 
nectin-derived tetrapeptide.  Exp.  Cell Res.  162:347-362. 
Akiyama, S. K., E. Hasegawa, T. Hasegawa, and K. M. Yamada. 1985. The 
interaction of fibronectin fragments with fibroblastic  cells. J.  Biol. Chem. 
260:13256-13260. 
Akiyama, S. K., S. S. Yamada, and K. M. Yamade. 1986.  Characterization 
of a 140-kD avian cell surface antigen as a fibronectin-binding molecule. J. 
Cell Biol.  102:442-448. 
Bozyczko, D., and A. F. Horwitz.  1986.  The participation  of a putative cell 
surface receptor for laminin and fibronectin in peripheral neurite extension. 
J.  Neurosci.  6:124t-1251. 
Bronner-Fraser, M. 1985, Alterations in neural crest migration by a monoclonal 
antibody that affects cell adhesion. J.  Cell Biol.  101:610-617. 
Brown,  P. J.,  and R.  L. Juliano.  1985.  Selective  inhibition of fibronectin- 
mediated cell adhesion by monoclonal antibodies to a cell-surface glycopro- 
tein. Science (Wash. DC). 228:1448-1451. 
Cohen, J.  1977. Statistical  Power Analysis for the Behavioral Sciences. Aca- 
demic Press, Inc., NY. 36-37. 
Cole, G. J., D. Schubert, and L. Glaser.  1985. Cell-substratum adhesion in 
chick neural retina depends upon protein-heparan sulfate interactions. J. Cell 
Biol.  100:1192-1199. 
Decker, C., R. Greggs, K. Duggan, J. Stubbs, and A. Horwitz. 1984. Adhesive 
multiplicity in the interaction of embryonic fibroblasts and myoblasts with 
extracellular matrices. J.  Cell Biol.  99:1398-1404. 
Eisenbarth, G. S.,. F. S. Walsh, and M. Nirenberg. 1979. Monoclonal antibody 
to a  plasma membrane antigen of neurons. Proc. NatL Acd.  Sci.  USA. 
76:4913-4917. 
Furcht,  L.  T.  1983.  Structure  and  function of the  adhesive glycoprotein 
fibronectin.  Mod. Cell Biol.  1:53-117. 
Grinneli,  F.,  and  M.  F.  Feld.  1981.  Adsorption characteristics of plasma 
fibronectin  in relationship to biological activity. J.  Biomed.  Mater. Res. 
15:363-381. 
Hasegawa, T., E. Hasegawa, W.-T. Chen, and K. M. Yamada. 1985. Charac- 
terization of a membrane glycoprotein complex implicated in cell adhesion 
to fibronectin.  J.  Cell. Biochem.  28:307-318. 
Hayashi, M., and K. M. Yamada. 1983. Domain structure of the carboxy termi- 
nal half of human plasma fibronectin.  J.  Biol. Chem. 258:3332-3340. 
Horwitz, A., K. Duggan, R. Greggs, C. Decker, and C. Buck. 1985. The cell 
substrate attachment (CSAT) antigen has properties of a receptor for laminin 
and fibronectin.  J.  Cell Biol. 101:2134-2144. 
Humphries, M.  J.,  S.  K.  Akiyama, A.  Komoriya,  K.  Olden,  and  K. M. 
Yamada. 1986. Identification of  an alternatively spliced site in human  plasma 
fibronectin that mediates cell type-specific  adhesion. J. Cell Biol. 103:2637- 
2647. 
Hynes, R. O.  1986.  Fibronectins. Sci, Am.  254:42-51. 
Izzard, C. S., R. Radinsky, and L. A. Culp.  1986.  Substratum contacts and 
cytoskeletal reorganization of BALB/c 3T3 cells on a cell-binding fragment 
and  beparin  binding  fragments of plasma  fibronectin.  Exp. Cell  Res. 
165:320-336. 
Knudsen, K. A., A. F. Horwitz, and C. A. Buck. 1985. A monoclonal antibody 
identifies a glycoprotein complex in cell-substratum  adhesion. Exp. Cell Res. 
157:218-226. 
Laterra, J., J. E. Silbert, and L. A. Culp.  1983. Cell surface heparan sulfate 
mediates some adhesive responses to glycosaminoglycan-binding  matrices, 
including fibronectin.  J.  Cell Biol.  96:112-123. 
Letourneau, P. C.  1975.  Cell-to-substratum adhesion and guidance of axonal 
elongation. Dev.  Biol. 44:92-102. 
Letourneau, P., I. Pech, M. McCarthy, S. Palm, and L. Furcht. 1986. Modula- 
tion of growth cone movement on surfaces coated with fibronectin and lami- 
nin. 3'. Neurosci.  12:1334.  (Abstr.) 
Loring, J., B. Glimelius, and J. A. Weston. 1982. Extracellular matrix mate- 
rials influence quail neural crest cell differentiation  in vitro. Dev. Biol. 90: 
165-174. 
Matthew, W. D., R. J. Greenspan, A. D. Lander, and L. F. Reichert. 1985. 
Immunopurification and characterization of a neuronal heparan sulfate pro- 
teoglycan. J. Neurosci.  5:1842-1850. 
McCarthy, J. B., S. T. Hagen, and L. T. Furcht. 1986. Human fibronectin con- 
rains distinct adhesion- and motility-promoting  domains for metastatic mela- 
home cells. J.  Cell Biol.  102:179-188. 
Palm, S. L., and L. T. Furcht. 1983. The production of laminin and fibronectin 
by Sehwannoma  cells: cell-protein interactions in vitro and protein localiza- 
tion in peripheral nerve in vivo. J.  Cell Biol.  96:1218-1226. 
Perkins, M. E., H. Ji Tae, and R. O. Hynes. 1979. Cross-linking  of fibronectin 
to sulfated proteoglycans at the cell surface. Cell. 16:941-952. 
Pierschbacher, M. D., E. G. l-layman, and E. Rnoslahti. 1981. Location of the 
cell-attachment  site in fibronectin with monoclonal antibodies and proteolytic 
fragments of the molecule. Cell. 26:259-267. 
Pierschbacher, M.  D., and E. Rnoslahti.  1984a.  Cell attachment activity of 
fibronectin can be duplicated by small synthetic fragments of the molecule. 
Nature  (Lond.). 309:30-33. 
Pierschbaeher, M. D., and E. Ruoslahti. 1984b. Variants of  the cell recognition 
site of fibronectin that retain attachment promoting activity, Proc.  Natl. 
Acad.  Sci. USA. 81:5985-5988. 
Pytela, R., M. D. Pierschbacher, and E. Ruoslahti. 1985. Identification and iso- 
lation of a  140 kd cell surface glycoprotein with properties expected of a 
fibronectin receptor. Cell. 40:191-198. 
Ratner, N., R. P. Bunge, and L. Glaser. 1985. A neuronal cell surface heparan 
sulfate proteoglycan is required for dorsal root ganglion neuron stimulation 
of Schwann cell proliferation. J.  Cell Biol.  101:744-754. 
Rogers, S. L., P. C. Letoumeau, S. L. Palm, J. B. McCarthy, and L. T. Furcht. 
1983.  Neurite extension by peripheral and central nervous system neurons 
in response to substratum-bound  fibronecfin and laminin. Dev. Biol. 98:212- 
220. 
Rogers, S. L., J. B. McCarthy, S. L. Palm, L. T. Furcht, and P. C. Letournean. 
1985. Neuron-specific interactions with two neurite-promoting fragments of 
fibronectin. J. Neurosci.  5:369-378. 
Rovasio, R. A., A. Delouvee, K. M. Yamada, R. Timpl, and J, P. Thiery. 
1983.  Neural crest cell migration: requirements for exogenous fibronectin 
and high cell density, J.  Celt Biol.  96:462-473. 
Rnoslahti, E., E. G. Hayman, and M. D. Pierschbacher. 1985.  Extracellular 
matrices and cell adhesion. Arteriosclerosis.  5:581-594. 
Sehnitzer, J., and M. Schnacher. 1982. Cell type specificity of a neural cell sur- 
face antigen recognized by the monoclonal antibody A2Bs. Cell l~ssue Res. 
224:625-636. 
Schubert, D., and M. LaCorbiere. 1985. Isolation of a cell surface receptor for 
chick neural retina adherons. J.  Cell Biol.  100:56-63. 
Smith, D. E., and L. T. Furcht. 1982. Localization of two unique heparin bind- 
ing domains of human plasma fibronectin  with monoclonal antibodies. J. 
BIOL Chem. 257:64518-64523. 
Smith, D. E., D. F. Mosher, R. B. Johnson, and L. T. Furcht. 1982. Immuno- 
logical  identification  of two  sulfhydryl-containing fragments of human 
plasma fibronectin. J. Biol.  Ozem. 257:5831-5838. 
Tobey, S. L., K. J. McClelland, and L. A. Culp. 1985.  Neurite extension by 
neuroblastoma  cells on substratum-bound  fibronectin's cell-binding fragment 
but not on the heparan sulfate-binding protein, platelet-factor-4.  Exp. Cell 
Res.  158:395-412. 
Tooney, N. M., M. W. Mosesson, D. L. Amrani, J.  F. Hainfeld, and J.  S. 
Wall. 1983. Solution and surface effects on plasma fibronectin structure. J. 
Cell Biol.  97:1686-1692. 
Urushihara, H., and K. M. Yamada. 1986. Evidence for involvement of more 
than one class of glycoprotein in cell interaction with fibronectin.  J.  Cell. 
Physiol.  126:323-332. 
Weston,  J. A. 1980. Role of the embryonic environment  in neural crest morpho- 
genesis. In Current Research Trends in Prenatal Craniofacial Development. 
R. M. Pratt and R. L. Christiansen, editors. Elsevier North Holland, Inc., 
Amsterdam. 27-45. 
Woods, A., M. Hook, L. Kjellen, C. G. Smith, and D. A. Rees. 1984. Relation- 
ship of heparan sulfate proteoglycans to the cytoskeleton and extracellular 
matrix of cultured fibroblasts.  J.  Cell. Biol. 99:1743-1753. 
Woods, A., J. R. Couchman, S. Johansson, and M. Hook. 1986. Adhesion and 
cytoskeletal  organization of fibroblasts in response to fibronectin  fragments. 
EMBO (Eur. Mol, Biol. Organ.) J.  5:665-670. 
Yamada, K. M.  1983.  Cell surface interactions with extracellular materials. 
Annu.  Rev. Biochem.  52:761-799. 
Yamada, K. M., D. R, Critchley, P. H. Fishman, and J. Moss. 1983. Exoge- 
nous gangliosides enhance the interaction of fibronectin with ganglioside- 
defcient ceils. Exp. Cell Res.  143:295-302. 
Yamada, K. M., and D. W. Kennedy. 1984. Dualistic nature of adbesive pro- 
tein function: fibronectin and its biologically active peptide fragments can 
autoinhibit flbronectin function. J.  Ceil Biol.  99:29-36. 
The Journal of Cell Biology, Volume 105,  1987  1442 